Once-nightly narcolepsy drug formula may benefit sleepyheads
21 May 2021
byAudrey Abella
Use of FT218, an investigational, once-nightly, controlled-release formulation of sodium oxybate (SO), led to clinically significant improvements in sleep parameters in individuals with narcolepsy, according to the secondary endpoint data from the pivotal phase III REST-ON* trial presented at AAN 2021.
